ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 452

Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use

Lorie Geryk1, Susan J. Blalock2, Robert DeVellis3, Joanne M. Jordan3 and Delesha Carpenter4, 1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, 2Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 4Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: health behaviors, Mediation, Osteoarthritis, patient engagement and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Few studies have described how patient, disease-specific, and provider factors are associated with medication information source use among arthritis patients. We address this research gap by describing characteristics associated with arthritis patients’ use of 15 medication information sources.

Methods: Adult osteoarthritis or rheumatoid arthritis patients completed an online cross-sectional survey. Patients (n=328) self-reported sociodemographic (i.e., age, gender, race/ethnicity, education level, marital status), clinical (i.e., year of diagnosis, age at diagnosis, arthritis type, current number of arthritis medicines taken, medication adherence, arthritis severity, comorbidities), and sociobehavioral (satisfaction with doctor-provided medication support, medication self-efficacy, and arthritis medication-taking concerns) characteristics. Patients were asked how much medicine information they sought and/or were given from fifteen different information sources (e.g., doctor, Internet, spouse/partner, medicine package inserts) when they are prescribed a new arthritis medicine. Patients’ responses (range:   1= “none” to 4= “a lot”) were averaged and higher mean scores corresponded to greater medication information source use. Correlations were inspected and covariates significant at the p≤0.05 level were subsequently examined using multivariable linear regression analyses to investigate whether sociodemographic, clinical, and sociobehavioral factors were associated with medication source use.

Results: On average, patients were 56 years old (±13; range 19–85) and were taking 2.5 arthritis medications. Most patients were female (79%) and white (80%); the median arthritis duration was 11 years. In multivariate analysis, the following independent variables remained significantly positively associated with arthritis medication information source use:  always adherent (b = .13, p =.024), more medications taken ((b = .09, p <.0001), more medicine-taking concerns (b = .11, p =.001), more satisfaction with doctor medication support (b = .21, <.007), and Black race (b= .25, =.002).

Conclusion: Information source use varied with patient, clinical, and sociobehavioral factors. These findings have implications for public health efforts related to medication education for arthritis patients.


Disclosure: L. Geryk, None; S. J. Blalock, None; R. DeVellis, None; J. M. Jordan, None; D. Carpenter, None.

To cite this abstract in AMA style:

Geryk L, Blalock SJ, DeVellis R, Jordan JM, Carpenter D. Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/associations-between-arthritis-patient-disease-specific-and-provider-characteristics-and-medication-information-source-use/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-between-arthritis-patient-disease-specific-and-provider-characteristics-and-medication-information-source-use/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology